Welcome to our dedicated page for Ticketplus news (Ticker: TP), a resource for investors and traders seeking the latest updates and insights on Ticketplus stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ticketplus's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ticketplus's position in the market.
Ticketplus (TP) completed its first acquisition since its August 2026 IPO by buying Argentine ticketing company Autoentrada S.A., converting a long‑standing white‑label partnership into full operations in Argentina.
Autoentrada, based in Córdoba, has operated in Argentina since 1999 and has used the Ticketplus platform under a white‑label model since 2019. The deal gives Ticketplus direct relationships with local promoters and greater control over sales, payments, access and analytics, and expands its own brand presence beyond Chile into Argentina, its second full‑operation market alongside nine other countries served via white‑label partners.
Autoentrada operates in 18 Argentine provinces, has managed more than 55,000 events and issued over 18 million tickets. Founder Eric López becomes Country Manager for Argentina, leading the local team. Ticketplus acquired all issued and outstanding shares of Autoentrada and does not expect a material impact on its consolidated 2026 financial results; financial terms were not disclosed.
Ticketplus (NYSE American: TP) reported strong results for the six months ended June 30, 2026, with revenue up 68% year-over-year to $22.8 million and second-quarter revenue growth accelerating to 81% year-over-year. Total platform sales (GMV) rose approximately 124% to $280.3 million, already surpassing full-year 2025 GMV of $268.9 million.
Gross profit margin expanded from 38.7% to 49.0%. Net profit increased 151% to $4.1 million, lifting net margin to 18.0%. EBITDA grew about 109% to $9.6 million, with a 42.1% margin. Cash flow from operations increased 30% to $8.2 million. As of June 30, 2026, cash and cash equivalents were $3.8 million, excluding approximately $15.5 million of net proceeds from Ticketplus’ August 10, 2026 initial public offering on NYSE American.
Ticketplus (NYSE American: TP) announced the closing of its initial public offering of 1,875,000 ordinary shares at $8.00 per share, generating $15 million in gross proceeds before underwriting discounts, commissions and other offering expenses. The company also granted underwriters a 45-day option to purchase up to 281,250 additional shares at the IPO price, less underwriting discounts and commissions.
Ticketplus’ ordinary shares began trading on NYSE American on August 7, 2026 under the ticker “TP”. Roth Capital Partners, Bancroft Capital and MDB Capital served as joint book-running managers for the offering.
Ticketplus (NYSE American: TP) priced its initial public offering at $8.00 per share, issuing 1,875,000 ordinary shares for expected gross proceeds of $15 million before fees. The company granted underwriters a 45‑day option to buy up to 281,250 additional shares at the IPO price, less discounts and commissions.
Ticketplus’ ordinary shares are expected to begin trading on NYSE American on August 7, 2026, under the symbol “TP,” with closing anticipated on or about August 10, 2026, subject to customary conditions. Roth Capital Partners, Bancroft Capital and MDB Capital are joint book‑running managers.